Argenx Se (ARGX) Interest & Investment Income (2016 - 2026)

Argenx Se's (ARGX) quarterly Interest & Investment Income came in at $48.0 million in Q2 2026, up 25.0% YoY from $38.4 million in Q2 2025, and up 9.09% on a QoQ basis from $44.0 million in Q1 2026.

Argenx Se (ARGX) Interest & Investment Income (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has 11 years of Interest & Investment Income data on file, last reported at $48.0 million in Q2 2026.

  • Quarterly Interest & Investment Income rose 25.0% year-over-year to $48.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $179.6 million (up 15.79% YoY) and the FY2025 annual result came in at $163.1 million, up 3.54% from the prior year.
  • Interest & Investment Income advanced to $48.0 million in Q2 2026, from $44.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $48.0 million in Q2 2026 to a low of $821000.0 in Q1 2022.
  • A 5-year average of $30.4 million and a median of $38.6 million in 2024 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2023 — Interest & Investment Income soared 1920.46% — and 2025, when it retreated 4.87%.
  • Tracing ARGX's Interest & Investment Income over 5 years: stood at $13.9 million in 2022, then soared by 189.46% to $40.3 million in 2023, then dropped by 3.01% to $39.1 million in 2024, then climbed by 14.78% to $44.9 million in 2025, then climbed by 6.97% to $48.0 million in 2026.
  • The last three Interest & Investment Income figures came in at $48.0 million (Q2 2026), $44.0 million (Q1 2026), and $44.9 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 48.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 35.58 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 27.90 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 5.13 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 28.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 10.98 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 36.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 48.00 Mn
Mar 31, 2026 44.00 Mn
Dec 31, 2025 44.87 Mn
Sep 30, 2025 42.70 Mn
Jun 30, 2025 38.40 Mn
Mar 31, 2025 37.00 Mn
Dec 31, 2024 39.10 Mn
Sep 30, 2024 40.59 Mn
Jun 30, 2024 38.93 Mn
Mar 31, 2024 38.90 Mn
Dec 31, 2023 40.31 Mn
Sep 30, 2023 30.05 Mn
Jun 30, 2023 20.44 Mn
Mar 31, 2023 16.59 Mn
Dec 31, 2022 13.93 Mn
Sep 30, 2022 8.01 Mn
Jun 30, 2022 4.91 Mn
Mar 31, 2022 821,000.00
Dec 31, 2021 1.20 Mn
Sep 30, 2021 805,000.00